Introduction...
Who We Are...
At mgl is an international biopharmaceutical company. Having a diverse portfolio of products and product candidates, with a focus in the areas of Oncology, Cardiology & Gastroenterology. As part of our unwavering commitment to improve patients’ lives, we are continuing to expand our commercial product portfolio through our research and development pipeline in therapeutic areas that can leverage our unique expertise.
Our Culture...
we have a strong patient-focused culture at MG lifecare that our employees believe in and pursue every day. Each member of our team makes integral contributions and is working toward a common goal to improve parients lives.
Everything we do at MG Lifecare is focused on three things:
- Putting patients
- Being a great place to work.
- Living our core values-integrity, collaboration, passion, pursuit of excellence and innovation.
Our Mission...
Our mission is to improve patients’ live by identifying developing, and commercializing meaningful products that address unmet medical needs.
Our Core Strength
Industry Leading Research Skills...
Our core team is strength and our network in the filed of research & innovation operates continuously to identify latest therapies with evaluation of safety gives an edge over the market to bring first in class treatment directly to consumers.
Deep Market Presence...
We endeavor a long industry experience in the areas of development manufacturing & research. With presence at 20 cities in India with over 75+ headquarters, effortlessly working on enhancing therapies & the clinical practice of clinicians.
Early Mover Advantage...
Our most of the therapies & solutions are strictly governed under exclusivity contracts with our principals and we taste success due to our untiring efforts we put to bring unique therapies for the frist time in the therapeutic segment.
Integrated Modren Infrastructure...
We are supported from & we extend our support to our R&D centers operated by principals to continuously develop and work in the areas of non-treatable & orphan diseases, further the manufacturing facilities in india are accrorded with strict GMP guidelines & world class analytical & production infrastructure.
Our Belief of Target...
The Journey Ahead...
Launched at 75+ HQs acroos 20 cities in india in 2023 & we intend to increase 150+ HQs by 2025
Therapy Sales Targets...
We value number of patients treated by our therapies over total value of sales generated; by the end of 2024 we are looking to improve lives of over 100000 patients across India under various therapeutic areas.
Milestones To Achieve...
We don't belive in market share; we trust in creating a market with our unique & first in class therapies and we are comited to accommodate every important stakeholder in our success journey as we belive happiness is in togetherness.
Our Brand
